Abstract
Purpose
There is little data and lack of consensus regarding antiplatelet management for intracranial stenting due to underlying intracranial atherosclerosis in the setting of endovascular treatment (EVT). In this DELPHI study, we aimed to assess whether consensus on antiplatelet management in this situation among experienced experts can be achieved, and what this consensus would be.
Methods
We used a modified DELPHI approach to address unanswered questions in antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of EVT. An expert-panel (19 neurointerventionalists from 8 countries) answered structured, anonymized on-line questionnaires with iterative feedback-loops. Panel-consensus was defined as agreement ≥ 70% for binary closed-ended questions/≥ 50% for closed-ended questions with > 2 response options.
Results
Panel members answered a total of 5 survey rounds. They acknowledged that there is insufficient data for evidence-based recommendations in many aspects of antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of EVT. They believed that antiplatelet management should follow a standardized regimen, irrespective of imaging findings and reperfusion quality. There was no consensus on the timing of antiplatelet-therapy initiation. Aspirin was the preferred antiplatelet agent for the peri-procedural period, and oral Aspirin in combination with a P2Y12 inhibitor was the favored postprocedural regimen.
Conclusion
Data on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of EVT are limited. Panel-members in this study achieved consensus on postprocedural antiplatelet management but did not agree upon a preprocedural and intraprocedural antiplatelet regimen. Further prospective studies to optimize antiplatelet regimens are needed.
Similar content being viewed by others
Change history
14 June 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00234-021-02735-6
References
C D (2018) How to train your oracle: the Delphi method and its turbulent youth in operations research and the policy sciences. Soc Stud Sci 48:846–868. https://doi.org/10.1177/0306312718798497
Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Rovira A, Sastre-Garriga J, Tintore M, Frederiksen JL, Gasperini C, Palace J, Reich DS, Banwell B, Montalban X, Barkhof F, Group MS (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 15(3):292–303. https://doi.org/10.1016/S1474-4422(15)00393-2
Meves SH, Neubauer H, Overbeck U, Endres HG (2011) Is there an ideal way to initiate antiplatelet therapy with aspirin? A crossover study on healthy volunteers evaluating different dosing schemes with whole blood aggregometry. BMC Res Notes 4:106. https://doi.org/10.1186/1756-0500-4-106
Baek JH, Kim BM, Heo JH, Kim DJ, Nam HS, Kim YD (2018) Outcomes of endovascular treatment for acute intracranial atherosclerosis-related large vessel occlusion. Stroke 49(11):2699–2705. https://doi.org/10.1161/STROKEAHA.118.022327
Chang Y, Kim BM, Bang OY, Baek JH, Heo JH, Nam HS, Kim YD, Yoo J, Kim DJ, Jeon P, Baik SK, Suh SH, Lee KY, Kwak HS, Roh HG, Lee YJ, Kim SH, Ryu CW, Ihn YK, Kim B, Jeon HJ, Kim JW, Byun JS, Suh S, Park JJ, Lee WJ, Roh J, Shin BS, Kim JM (2018) Rescue stenting for failed mechanical thrombectomy in acute ischemic stroke: a multicenter experience. Stroke 49(4):958–964. https://doi.org/10.1161/STROKEAHA.117.020072
Nappini S, Limbucci N, Leone G, Rosi A, Renieri L, Consoli A, Laiso A, Valente I, Rosella F, Rosati R, Mangiafico S (2019) Bail-out intracranial stenting with Solitaire AB device after unsuccessful thrombectomy in acute ischemic stroke of anterior circulation. J Neuroradiol 46(2):141–147. https://doi.org/10.1016/j.neurad.2018.05.004
Woo HG, Sunwoo L, Jung C, Kim BJ, Han MK, Bae HJ, Bae YJ, Choi BS, Kim JH (2018) Feasibility of permanent stenting with solitaire FR as a rescue treatment for the reperfusion of acute intracranial artery occlusion. AJNR Am J Neuroradiol 39(2):331–336. https://doi.org/10.3174/ajnr.A5477
Kim KS, Fraser JF, Grupke S, Cook AM (2018) Management of antiplatelet therapy in patients undergoing neuroendovascular procedures. J Neurosurg 129(4):890–905. https://doi.org/10.3171/2017.5.JNS162307
Thompson BG, Brown RD Jr, Amin-Hanjani S, Broderick JP, Cockroft KM, Connolly ES Jr, Duckwiler GR, Harris CC, Howard VJ, Johnston SC, Meyers PM, Molyneux A, Ogilvy CS, Ringer AJ, Torner J, American Heart Association Stroke Council CoC, Stroke N, Council on E, Prevention, American Heart A, American Stroke A (2015) Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46(8):2368–2400. https://doi.org/10.1161/STR.0000000000000070
Adeeb N, Griessenauer CJ, Foreman PM, Moore JM, Shallwani H, Motiei-Langroudi R, Alturki A, Siddiqui AH, Levy EI, Harrigan MR, Ogilvy CS, Thomas AJ (2017) Use of platelet function testing before pipeline embolization device placement: a multicenter cohort study. Stroke 48(5):1322–1330. https://doi.org/10.1161/STROKEAHA.116.015308
Brinjikji W, Lanzino G, Cloft HJ, Siddiqui AH, Hanel RA, Kallmes DF (2015) Platelet testing is associated with worse clinical outcomes for patients treated with the pipeline embolization device. AJNR Am J Neuroradiol 36(11):2090–2095. https://doi.org/10.3174/ajnr.A4411
Acknowledgments
None
Funding
There was no funding for this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Johanna Ospel is supported by the University of Basel Research Foundation, Julia Bangerter Rhyner Foundation and Freiwillige Akademische Gesellschaft Basel. Mayank Goyal is a consultant for Medtronic, Stryker, Microvention, GE Healthcare, Mentice. The remaining authors have nothing to disclose.
Ethical approval
For this type of study, approval from an ethics board is not required since no patient data were used. All participants gave their consent prior to answering the survey questions.
Informed consent
Since the study did not involve patients, formal consent from patients is not required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 22 kb)
Rights and permissions
About this article
Cite this article
Goyal, M., Orlov, K., Jensen, M.E. et al. A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy. Neuroradiology 63, 627–632 (2021). https://doi.org/10.1007/s00234-020-02556-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-020-02556-z